On February 14 ProMIS Neurosciences (PMN) separated with Gavin T. Malenfant as Chief Operating Officer of the Company, effective as of February 14… In connection with the Separation, Malenfant and the company intend to enter into a Separation Agreement pursuant to which Malenfant will receive severance benefits in exchange for a release pursuant to the terms of his employment agreement with the company… The company also terminated the Chief Operating Officer position, and does not intend to replace Mr. Malenfant. This information is contained in a company 8k filing…
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PMN: